Unmanaged Type 2 Diabetes is Expensive For Employers

Unmanaged Type 2 Diabetes is Expensive For Employers

Posted Dec 1, 2017

Educating employees about their medications and modifying habits will result in increased adherence to prescribed maintenance medications, as well as illuminating other blind spots.  PharmMD has a strategic plan to save lives and create healthier individuals. Read our case study.

Rising Diabetes Rates Are Costly for Employers

Source: SHRM published on November 14, 2017

About PharmMD: PharmMD is a leading healthcare technology company providing data-driven medication adherence platform solutions that deliver value-based care outcomes. PharmMD partners with health plans, providers and other risk-bearing entities seeking to improve patient and employee healthcare through better medication adherence. Founded by healthcare and pharmaceutical innovators, PharmMD’s outcomes-driven solutions bolster initiatives in quality improvement and related regulatory compliance through better medication adherence. For more information, please visit www.pharmmd.com.